CONMED Corporation Announces Third Quarter 2019 Financial Results

Go back to CONMED Corporation Announces Third Quarter 2019 Financial Results

Conmed (CNMD) Tops Q3 EPS by 6c; Raises Outlook

October 30, 2019 4:06 PM EDT

Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.62, $0.06 better than the analyst estimate of $0.56. Revenue for the quarter came in at $233.6 million versus the consensus estimate of $227.93 million.

GUIDANCE:

Conmed sees FY2019 EPS of $2.62-$2.65, versus prior of $2.52-$2.57 and the... More